When thalidomide came to market in the 1950s as a morning sickness treatment, no one imagined the many cases of birth defects that would result from use of the drug. More than 50 years later, a small Madison-based stem cell company is selling a research product that could have prevented what some have called one of the biggest medical tragedies of modern times. Read full Journal Sentinel story here.
- ‘Office hours’ offer expert advice for emerging firms at March 18 Lambeau Tech SummitFebruary 19, 2019
- WisBiz: The Show’ covers Tech Metrics, Tom Still commentary; interview with Sean RobertsFebruary 18, 2019
- ‘Reverse pitch’ by healthcare providers part of March 18 Tech Summit at LambeauFebruary 14, 2019
- InsideWis: Company speed dates aimed at matching big, emerging businessesFebruary 14, 2019
- How ‘smart’ is your city? Learn more at March 7 Tech Council event in WauwatosaFebruary 14, 2019